Purchase Order 75N95019P00517
Award Date 8/12/19
Potential Completion Date 9/11/19
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
- The National Institutes of Health (NIH) awarded a $75,705.70 firm fixed-price purchase order contract to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, to provide PathHunter cell lines, reagents, and kits. The contract supports the Therapeutics for Rare and Neglected Diseases (TRND) program at the National Center for Advancing Translational Sciences (NCATS) within the NIH. The requested products will be used to develop dopamine D3 receptor antagonists for the...
- This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx LLC, a foreign-owned for-profit organization based in Fremont, California. The contract, which does not have a set-aside designation, is for stable cell line screening services to support compound discovery research. The fixed-price contract has a ceiling value of $24,985.40 and an ultimate completion date of December 30,...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
- This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order valued at approximately $1 million to Eurofins Discoverx Products, LLC for binding studies. The contract is to be performed in Fremont, California over a one year period ending August 2024. Eurofins Discoverx will provide binding assay services in support of NIH's efforts to facilitate the movement of scientific observations...
- This is a $20,823.14 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to Eurofins Discoverx LLC, a foreign-owned for-profit organization. The purpose is to test 30 compounds for binding to IRAK and FLT3 kinases over a 1-year period of performance from September 16, 2020 to September 15, 2021. This award was made through a non-competitive combined synopsis/solicitation process under simplified acquisition procedures...